Evidence map›Paper›PMID 37198558›Full record

ArticleBMC ophthalmology2023

Stereoptic serious games as a visual rehabilitation tool for individuals with a residual amblyopia (AMBER trial): a protocol for a crossover randomized controlled trial.

Cristina Simon-Martinez, Maria-Paraskevi Antoniou, Walid Bouthour, Daphne Bavelier, Dennis Levi, Benjamin T Backus, Brian Dornbos, James J Blaha, Martina Kropp, Henning Müller and 4 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMC ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05114252 (Stereoptic Serious Games as a Visual Rehabilitation Tool for Individuals With Residual Amblyopia), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05114252 naunknown statusnot on this map

Stereoptic Serious Games as a Visual Rehabilitation Tool for Individuals With Residual Amblyopia: A Crossover Randomized Controlled Trial - AMBlyopia and stEReoptic Games for Vision

TypeinterventionalSponsorPawel Matusz, PhDRan2022 to 2024Enrolled30ConditionsAmblyopia, HealthyArmsVivid Vision Home, Refractive error correction
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Cristina Simon-MartinezUniversity of Applied Sciences Western Switzerland (HES-SO) Valais-Wallis, Rue de Technopole 3, 3960, Sierre, Switzerland. cristina.simon@hevs.ch.
Maria-Paraskevi AntoniouUniversity of Applied Sciences Western Switzerland (HES-SO) Valais-Wallis, Rue de Technopole 3, 3960, Sierre, Switzerland.
Walid BouthourDepartment of Ophthalmology, University Hospitals of Geneva, Geneva, Switzerland.
Daphne BavelierFaculty of Psychology and Education Sciences, University of Geneva, Geneva, Switzerland.
Dennis LeviHerbert Wertheim School of Optometry & Vision Science, Helen Wills Neuroscience Institute, University of California Berkley, Berkley, CA, USA.
Benjamin T BackusVivid Vision, Inc, 424 Treat Ave., Ste B, San Francisco, CA, 94110, USA.
Brian DornbosVivid Vision, Inc, 424 Treat Ave., Ste B, San Francisco, CA, 94110, USA.
James J BlahaVivid Vision, Inc, 424 Treat Ave., Ste B, San Francisco, CA, 94110, USA.
Martina KroppDepartment of Ophthalmology, University Hospitals of Geneva, Geneva, Switzerland.
Henning MüllerUniversity of Applied Sciences Western Switzerland (HES-SO) Valais-Wallis, Rue de Technopole 3, 3960, Sierre, Switzerland.
Micah MurrayThe Sense Innovation and Research Center, Lausanne and Sion, Sion, Switzerland.
Gabriele ThumannDepartment of Ophthalmology, University Hospitals of Geneva, Geneva, Switzerland.
Heimo Steffen *Department of Ophthalmology, University Hospitals of Geneva, Geneva, Switzerland.
Pawel J Matusz *University of Applied Sciences Western Switzerland (HES-SO) Valais-Wallis, Rue de Technopole 3, 3960, Sierre, Switzerland.
HES-SO Valais-Wallis · CHUniversity Hospital of Geneva · CHUniversity of Geneva · CHThe Sense Innovation and Research Center

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAmblyopia is the most common developmental vision disorder in children. The initial treatment consists of refractive correction. When insufficient, occlusion therapy may further improve visual acuity. However, the challenges and compliance issues associated with occlusion therapy may result in treatment failure and residual amblyopia. Virtual reality (VR) games developed to improve visual function have shown positive preliminary results. The aim of this study is to determine the efficacy of these games to improve vision, attention, and motor skills in patients with residual amblyopia and identify brain-related changes. We hypothesize that a VR-based training with the suggested ingredients (3D cues and rich feedback), combined with increasing the difficulty level and the use of various games in a home-based environment is crucial for treatment efficacy of vision recovery, and may be particularly effective in children.

methodsThe AMBER study is a randomized, cross-over, controlled trial designed to assess the effect of binocular stimulation (VR-based stereoptic serious games) in individuals with residual amblyopia (n = 30, 6-35 years of age), compared to refractive correction on vision, selective attention and motor control skills. Additionally, they will be compared to a control group of age-matched healthy individuals (n = 30) to account for the unique benefit of VR-based serious games. All participants will play serious games 30 min per day, 5 days per week, for 8 weeks. The games are delivered with the Vivid Vision Home software. The amblyopic cohort will receive both treatments in a randomized order according to the type of amblyopia, while the control group will only receive the VR-based stereoscopic serious games. The primary outcome is visual acuity in the amblyopic eye. Secondary outcomes include stereoacuity, functional vision, cortical visual responses, selective attention, and motor control. The outcomes will be measured before and after each treatment with 8-week follow-up. DISCUSSION: The VR-based games used in this study have been conceived to deliver binocular visual stimulation tailored to the individual visual needs of the patient, which will potentially result in improved basic and functional vision skills as well as visual attention and motor control skills.

trial registrationThis protocol is registered on ClinicalTrials.gov (identifier: NCT05114252) and in the Swiss National Clinical Trials Portal (identifier: SNCTP000005024).

Indexed as

AmblyopiaVideo GamesChildHumansRandomized Controlled Trials as TopicTreatment OutcomeVision, BinocularVisual AcuityAmblyopiaBinocular stimulationChildDichoptic stimulationElectroencephalographyKinematicsMotor controlOptical treatmentRefractive correctionStereovisionVirtual realityVisual attention

Identifiers

PMID37198558
PMCPMC10190050
OpenAlexW4377011234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.